TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Ankit Agarwal. I'm an associate with the investment banking group here at JPMorgan. It's my pleasure to introduce our next speaker, Mr. Michael Weiss, CEO of TG Therapeutics.
Great. Thank you so much for that lovely introduction. Thanks, JPMorgan for having us again, Thursday morning. It's our favorite slot. And thanks, everyone, who got up early on Thursday morning to join us.
So let me just get going here. Let's see if I got this. I've received very clear instructions on how to use this machine.
So before I get started, let me just mention, I will be making some forward-looking statements. For those of you who are interested, I do encourage you to look at our public disclosure documents available on the Internet, worldwide web.
So just by the way of background, we founded the company about 8 years ago with one goal in mind: to create the best possible
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |